Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review. | Oncologist | 2024 | 37995306 | PubTator, text mining | PubMed |
Identification of Novel and Early Biomarkers for Cisplatin-induced Nephrotoxicity and the Nephroprotective Role of Cimetidine using a Pharmacometabolomic-based Approach Coupled with In Vitro Toxicodynamic Modeling and Simulation. | J Pharm Sci | 2024 | 37992870 | PubTator, text mining | PubMed |
| Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells. | J Pharmacol Exp Ther | 2024 | 37977812 | PubTator, text mining | PubMed |
| Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway. | J Chin Med Assoc | 2024 | 37962398 | PubTator, text mining | PubMed |
| Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling. | Curr Drug Res Rev | 2024 | 37157206 | PubTator, text mining | PubMed |
| Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines. | J Pharm Pharm Sci | 2023 | 38304488 | PubTator, text mining | PubMed |
| Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow). | Bioengineering (Basel) | 2023 | 38275575 | PubTator, text mining | PubMed |
| Assessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders. | Pharmaceuticals (Basel) | 2023 | 38256895 | PubTator, text mining | PubMed |
| Sensitivity of Human Induced Pluripotent Stem Cells and Thereof Differentiated Kidney Proximal Tubular Cells towards Selected Nephrotoxins. | Int J Mol Sci | 2023 | 38203251 | PubTator, text mining | PubMed |
| The renal damage and mechanisms relevant to antitumoral drugs. | Front Oncol | 2023 | 38148845 | PubTator, text mining | PubMed |
| Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders. | Pharmaceuticals (Basel) | 2023 | 38139841 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
| Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms. | J Pers Med | 2023 | 38138916 | PubTator, text mining | PubMed |
| Thioacetamide-Induced Acute Liver Injury Increases Metformin Plasma Exposure by Downregulating Renal OCT2 and MATE1 Expression and Function. | Biomedicines | 2023 | 38137535 | PubTator, text mining | PubMed |
| Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma. | Clin Transl Sci | 2023 | 38129988 | PubTator, text mining | PubMed |
| Precision nephrotoxicity testing using 3D in vitro models. | Cell Biosci | 2023 | 38129901 | PubTator, text mining | PubMed |
| Multifunctional effect of flavonoids from Millettia brandisiana against Alzheimer's disease pathogenesis. | Heliyon | 2023 | 38106662 | PubTator, text mining | PubMed |
| Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage. | Front Cell Dev Biol | 2023 | 38099292 | PubTator, text mining | PubMed |
| A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons. | Front Med (Lausanne) | 2023 | 38093976 | PubTator, text mining | PubMed |
| Caged Polyprenylated Xanthones in Garcinia hanburyi and the Biological Activities of Them. | Drug Des Devel Ther | 2023 | 38076632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=7